MedTrace Logo

Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS)

NCT01865903 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2020-03-06

No results posted yet for this study

Summary

Weight loss and loss of lean body mass are common and associated with adverse outcomes such as loss of strength, reduced immune- and pulmonary function and increased disability in advanced cancer. Progressive weight loss interferes with cancer therapy and is responsible for reduced quality of life (QoL) as well as shorter survival irrespective of tumour mass or presence of metastases. Weight loss in advanced cancer is regarded as a major clinical challenge because of its serious consequences, its varying aetiology and the contribution of multiple pathophysiological mechanisms that are poorly disentangled.

Conditions

Sponsors & Collaborators

  • Diakonhjemmet Hospital

    collaborator OTHER

  • Lovisenberg Diakonale Hospital

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-15
Primary Completion
2020-02-04
Completion
2020-02-04

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01865903 on ClinicalTrials.gov